• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 8 hours
Drugmakers Accused of Causing Opioid Addiction in Trial The Wall Street Journal17:19 19-Apr-21
In the last 7 days
A Dividend Aristocrat On Sale: AbbVie Seeking Alpha08:43 15-Apr-21
Should AbbVie Be Worried About Rinvoq? The Motley Fool07:11 14-Apr-21
A Short Delay Is Still Bad News for AbbVie The Motley Fool08:07 13-Apr-21
In the last month
AbbVie: Buy The Humira Fear And Profit Seeking Alpha11:25 11-Apr-21
4 Green Flags for AbbVie in 2021 The Motley Fool06:38 11-Apr-21
Better Value Stock: AbbVie or Viatris? The Motley Fool06:03 10-Apr-21
What Will JAK Inhibitor Safety Jitters Mean For Drug Sales? Scrip Pharma Intelligence18:15 7-Apr-21
Should You Buy AbbVie in April? The Motley Fool07:26 6-Apr-21
AbbVie Declares Quarterly Dividend AbbVie (Press Release)17:16 27-Mar-21
Alvotech Disputes AbbVie’s Recent Allegations Business Wire (Press Release)10:57 25-Mar-21
AbbVie Accuses Alvotech of Trade Secret Piracy Center for Biosimilars15:45 24-Mar-21
view more headlines
19 Apr 17:19

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.